‘A vaccine for this, a vaccine for that – vaccines all around! If it isn’t a pharmaceutical drug, Western medicine seems to find a vaccine for everything. A possible ‘cure’ for Alzheimer’s disease is being offered in as little as five years if all 14,000,000-plus of the people who currently suffer from the disease (and oh, yes, their family members too) just subject themselves to a vaccine.
A Little Info on Alzheimer’s:
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
According to BrightFocus Foundation, more than 500,000 people will be diagnosed with Alzheimer’s this year just in the U.S. Annual prescription drug costs for people with Alzheimer’s are estimated at $3,000, three times the median cost for an average Medicare beneficiary, and this does not include the costs of mental health and memory care, hospice care, and other exorbitant costs which accompany the progression of the disease.
Full time care in a memory center for patients who can no longer feed themselves, use the bathroom for themselves, or walk on their own can cost upwards of $5000 a month. If 14 million people are already diagnosed with Alzheimer’s in the US and more than 500,000 people are going to be added to that list annually, you can easily surmise that this disease is the new ‘cancer’ of the pharmaceutical cartel.
With drug sales alone, this amounts to an excess of $42 billion annually for companies like Biogen and over 30 other Big Pharma companies. Soon, Alzheimer’s is projected to be a $3 trillion dollar annual expense to the healthcare system – but an easy trip to the bank for Big Pharma.
The Real Dangers of Many Big Pharma Solutions:
As with other FDA-approved drugs, the companies who make these pharmaceuticals get away with murder, too. Four months before a best-selling Alzheimer’s drug was set to lose its patent protection, its makers received approval for a higher dosage that extended their exclusive right to sell the drug. But the higher dosage caused potentially dangerous side effects and worked only slightly better than the existing drugs. The drug was essentially useless for Alzheimer’s patients and even damaging, yet received a patent.’